In this study, the first industrial-scale high-throughputscreeningof nearly 350,000 drug-like molecules targeting the enzyme 17β-HSD10,a promising therapeutic target for Alzheimer’s disease andcancers, is presented. The gene discussed is HSD17B10; the disease is Alzheimer disease.